Dr Sue Foden

Dr Sue Foden holds a number of non executive directorships with both public and private companies and public funding bodies in the biotech and healthcare field. Prior to this Sue held positions in VC, technology transfer and UK biotech.

From 2000 to 2003, she was an Investor Director with the London- based VC firm Merlin Biosciences Ltd. From 1987 to 2000 she was CEO of the Technology transfer company, CRCT, and from 1998 to 2000 also of Cancer Research Ventures [CRV].

From 1983 to 1987 Sue headed up the academic liaison function at what was then Celltech Ltd, dealing with some of the earliest tech transfer deals in the UK and the precedents that these set. Sue studied biochemistry at the Univ of Oxford from where she obtained her MA and DPhil degrees.

Stay in
the loop

Fill out the form to subscribe to our newsletter. Keep up to date with news and insights from our partners.